SCHEMBL8075680

SCHEMBL8075680

[c]1nc(NCc2ccccc2)cs1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.49
KMT2A Q03164 3/20 0.49
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 2/20 0.49
FABP1 P07148 1/20 0.49
FABP6 P51161 1/20 0.49
LMNA P02545 2/20 0.42
NOS2 P35228 1/20 0.42
GAA P10253 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KCNH3 Q9ULD8 1/20 0.42
ESR1 P03372 2/20 0.42
CXCR4 P61073 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 2/20 0.41
HCAR2 Q8TDS4 1/20 0.41
ESR2 Q92731 1/20 0.41
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2096590 0.83 KDM4E (0.51) HPGDKMT2AALDH1A1MEN1LMNA
SCHEMBL2094125 0.83 MEN1 (0.45) KMT2AALDH1A1MEN1LMNAGAA
SCHEMBL2089715 0.83 KDM4E (0.51) HPGDKMT2AALDH1A1MEN1GAA
SCHEMBL2093315 0.83 KDM4E (0.51) HPGDKMT2AALDH1A1MEN1LMNA
SCHEMBL2088493 0.80 EPHX2 (0.50) ALDH1A1KDM4E
SCHEMBL2094917 0.79 NPC1 (0.50) HPGDKMT2AMEN1LMNAGAA
SCHEMBL2096333 0.76 KCNN3 (0.44)
SCHEMBL11428118 0.69 FABP1 (0.50) HPGDKMT2AALDH1A1MEN1FABP1
SCHEMBL3596573 0.69 MMP13 (0.55) HPGDKMT2AALDH1A1SMN1; SMN2MAPK1
SCHEMBL206040 0.68 CALM1 (0.42) ALDH1A1L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0494733-A1 Trifluoromethyl 1-carba(1-dethia)cephems ELI LILLY AND COMPANY (US) 1992-07-15 EP claimed
US-5099015-A Antibiotics formed by bromination of trifluoromethanesulfonyl containing cephalosporins ELI LILLY AND COMPANY (US) 1992-03-24 US claimed
EP-0565351-B1 Process for preparing 7-substituted-amino-3-hydroxy-3-cephem-4-protected carboxy-sulfoxide esters LILLY CO ELI (US) 2000-08-23 EP disclosed
EP-0494118-B1 Process for 3-exomethylenecepham sulfoxide esters LILLY CO ELI (US) 1997-04-09 EP disclosed
US-5512454-A Enzymatic acylation of 3-hydroxymethyl cephalosporins BRISTOL-MYERS SQUIBB COMPANY (US) 1996-04-30 US disclosed
US-5453502-A 1,3,4 substituted and bicyclic derivatives of 2-azetidinones and processes for preparation thereof ELI LILLY AND COMPANY (US) 1995-09-26 US disclosed
EP-0672656-A1 1,3,4 substituted and bicyclic derivatives of 2-azetidinones and processes for preparation thereof ELI LILLY AND COMPANY (US) 1995-09-20 EP disclosed
EP-0667396-A1 Enzymatic acylation of 3-hydroxymethyl cephalosporins BRISTOL-MYERS SQUIBB COMPANY (US) 1995-08-16 EP disclosed
US-5350845-A Process for preparing 7-substituted-amino-3-hydroxy-3-cephem-4-protected carboxy-sulfoxide esters ELI LILLY AND COMPANY (US) 1994-09-27 US disclosed
EP-0565351-A2 Process for preparing 7-substituted-amino-3-hydroxy-3-cephem-4-protected carboxy-sulfoxide esters ELI LILLY AND COMPANY (US) 1993-10-13 EP disclosed
US-5221739-A Acetylation of 3-hydroxymethyl cephalosporins ELI LILLY AND COMPANY (US) 1993-06-22 US disclosed
EP-0494733-A1 Trifluoromethyl 1-carba(1-dethia)cephems ELI LILLY AND COMPANY (US) 1992-07-15 EP disclosed
EP-0494118-A1 Process for 3-exomethylenecepham sulfoxide esters ELI LILLY AND COMPANY (US) 1992-07-08 EP disclosed
US-5126446-A Cyclization of 3-methyl-2-(4-chlorosulfinyl-2-oxo-3-amino-1-azetidinyl)-3-butenoic acid esters using lewis acid friedel-crafts catalyst, nitro compound, anhydrous conditions ELI LILLY AND COMPANY (US) 1992-06-30 US disclosed
US-5099015-A Antibiotics formed by bromination of trifluoromethanesulfonyl containing cephalosporins ELI LILLY AND COMPANY (US) 1992-03-24 US disclosed